Skip to main content
OpenTrials
Completed

NCT Number: NCT01818609

Study of Inactivity on Metabolism of Elderly Muscles

Skeletal muscle mass declines with inactivity (casting is a good example) and increases with activity (such as weightlifting). Whether muscle mass increases or decreases, is determined by whether more new proteins within muscle are made than are broken down. The investigators know that feeding protein increases the synthesis of new proteins but that the response of older muscles to protein feeding is blunted compared with the young. This resistance of the elderly to muscle building stimuli may be the primary reason that muscle mass is lost in aging. The investigators also know that periods of muscle disuse such as casting result in a person's muscle shrinking due, the investigators believe, to a lower rate of synthesis of new muscle proteins. Age-related muscle loss begins around 50 years old and proceeds at approximately 1% for every year after. Elderly persons would likely fare well with advancing age if their muscle loss were simply linear; however, a rate of muscle loss of 1% annually is a 'population view' and does not represent what occurs during short periods of muscle disuse (i.e. during hospitalization or illness), which occur with increasing frequency in elderly persons. During periods of disuse, the resistance of elderly muscles to protein nutrition may be worsened. The investigators will measure how quickly new proteins are made at rest and after protein feeding in elderly men, before and after a 14 day period of reduced activity brought on by having people reduce their daily step count.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or Female
  • Aged 60 to 80 years old
  • Non-smoker Generally healthy and can tolerate the resistance exercise and protein drink

Exclusion criteria

  • Allergies to whey protein
  • Health problems such as: heart disease, rheumatoid arthritis of the knee joint, diabetes, poor lung function, uncontrolled hypertension, or any health conditions that might put participants at risks for this study
  • Failed an exercise stress test
  • Taking metformin and/or other medications for the control of blood glucose even though one might not be classified as diabetic
  • Taking prescribed blood thinners such as warfarin and heparin but excluding aspirin
  • Taking medications for lung and kidney conditions but excluding medication for asthma that is under control

Treatment and study plan

Step reduction

Behavioral

taking less than 1500 steps/d

Other names: Sedentary behaviour

Primary outcomes

  1. Fractional synthetic rate (FSR) of myofibrillar muscle protein

    Time frame: over 5h

    rate of making new muscle proteins

Secondary outcomes

  1. Blood amino acid concentrations

    Time frame: over 5h

    concentration of amino acids in blood

  2. Intramuscular signalling protein status

    Time frame: over 5h

    phosphorylation of key signalling proteins

  3. Insulin sensitivity via blood sampling

    Time frame: over 5h

    measure of insulin concentration

Sponsors and collaborators

Lead sponsor

McMaster University

Other

Registry information

Official study title

Influence of Reduce Daily Step Count on Muscle Protein Metabolism in Older Persons

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Mar 26, 2013
Registry last updated
Feb 25, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.